The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...

AI is becoming crucial in prostate cancer care, improving diagnosis and treatment stratification through enhanced imaging and risk assessment. AI-generated cancer mapping has shown superior accuracy ...

This article explores how advances in data, genomics and artificial intelligence are improving our ability to estimate ...

UT biochemistry major Milit Patel collaborated with researchers at Memorial Sloan Kettering Cancer Center on research published in a top cancer journal.

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

MADISON, Wis., May 7, 2025 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the ...

Cancer researchers have a new tool at their disposal that could help improve survival rates. Developed by University of Texas ...

Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...